Home / Stocks / CRSP

CRSP insider trading

CRISPR Therapeutics AG — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$53.0M
Buys · last 90 days
0 · $0
Most recent buy
2026-01-27

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-27Patel Naimish
Chief Medical Officer
Bought1,508$32.96$50k
2026-01-26Prasad Raju
Chief Financial Officer
Sold34,972$60.19$2.1M
2026-01-22Kulkarni Samarth
Chief Executive Officer
Sold81,433$57.96$4.7M
2026-01-08Prasad Raju
Chief Financial Officer
Sold18,933$60.18$1.1M
2025-10-20Kulkarni Samarth
Chief Executive Officer
Sold50,895$67.91$3.5M
2025-08-08Treco Douglas A
Director
Bought20,000$57.03$1.1M
2025-07-17George Simeon
Director
Bought989,812$52.03$51.5M
2025-02-28Greene John
Director
Bought7,000$44.85$314k
2025-02-21Kulkarni Samarth
Chief Executive Officer
Sold18,360$55.21$1.0M
2024-11-13Kulkarni Samarth
Chief Executive Officer
Sold23,121$55.43$1.3M

Most active insider buyers

InsiderRoleBuysTotal bought
George SimeonDirector1$51.5M
Treco Douglas ADirector1$1.1M
Greene JohnDirector1$314k
Patel NaimishChief Medical Officer1$50k

See CRSP on the chart

Every insider buy and sell for CRSP plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.